Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients
Clinical trial NCT02956772 · UNKNOWN
Trial details
- NCT number
- NCT02956772
- Sponsor
- Hunan Provincial People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2019-11-01
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.